Immunocore at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Immunocore brings 2 presentations to PEGS Europe 2026 in Lisbon. Its program covers T cell engagers aimed at peptide-HLA complexes and how to make them both specific and potent. It also covers a beta-cell targeted bispecific meant to change the course of type 1 diabetes.

OrganizationPEGS Europe 2026 Attendance
Immunocore
Abingdon, UK
immunocore.com
Biotech
Develops TCR bispecific medicines for cancer and autoimmune disease, with a marketed melanoma therapy.
Talk
Tue Nov 17
9:30am–10:00am
Engineering Specific and Potent T Cell Engagers Targeting pHLA
Safety and Efficacy of Bispecific and Multispecific Antibodies
Talk
Wed Nov 18
7:00pm–7:30pm
IMC-S118AI: beta-cell Targeted Bispecific for Type 1 Diabetes (T1D) Disease Modification
Biologics for Autoimmune Diseases

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Immunocore

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction